免費(fèi)咨詢熱線：
15522676233
尼羅替尼 Nilotinib Nilotinib, also known as AMN107, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
Dasatinib is a potent inhibitor of the non-receptor tyrosine kinases Abl and Src as well as other members of the Src family.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
伯舒替尼 Bosutinib Bosutinib, also known as SKI-606, is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl and Src kinases with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
維奈妥拉 Venetoclax Venetoclax, also known as ABT-199 or GDC0199, is an orally bioavailable, selective small molecule inhibitor of the anti-apoptotic protein Bcl-2, with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
勞拉替尼 Lorlatinib Lorlatinib, also known as PF-06463922, is an orally available, ATP-competitive inhibitor of the receptor tyrosine kinases, anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (Ros1)
更新時(shí)間：2023-07-12
廠商性質(zhì)：代理商
